Stock MAGLE MAGLE CHEMOSWED HOLDING AB
Add to a list
To use this feature you must be a member
Log inSign up

Company Magle Chemoswed Holding AB

Equities

MAGLE

SE0014401014

Pharmaceuticals

Market Closed - Nasdaq Stockholm
Other stock markets
 05:40:07 14/05/2024 pm IST 		5-day change 1st Jan Change
32.4 SEK 0.00% Intraday chart for Magle Chemoswed Holding AB +1.25% +28.57%
18/04 Magle Chemoswed Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
22/03 Magle Chemoswed Holding AB (OM:MAGLE) made a tender to acquire 99.96% stake in Amniotics AB (OM:AMNI) from LSCS Invest AB, Deflexum AB, Marcus Larsson and other for SEK 10.9 million. CI

Business Summary

Magle Chemoswed Holding AB is a Sweden-based company that conducts research, development and manufacturing in the fields of pharmaceutical chemistry and pharmaceutical technology. The Company's operations are mainly conducted through the subsidiaries Magle Chemoswed AB and Adroit Science AB. The business is focused on process development and manufacturing of Active Pharmaceutical Ingredients (API) as well as research, development and manufacturing of products in the areas of wound care and diagnostics with particular focus on products based on degradables starch microspheres. Magle Chemoswed also functions as a consultancy in material characterization and solid phase analysis with a main focus on pharmaceutical companies.

Number of employees: 78

Sales per Business

SEK in Million2021Weight2022Weight Delta
Magle Chemoswed AB
90.4 %
119 90.1 % 132 90.4 % +10.56%
PharmcaCept GmbH
11.6 %
11 8.0 % 17 11.6 % +59.32%
Internal Eliminations
-11.1 %
- - -16 -11.1 % -
Magle Chemoswed Holding AB
6.8 %
- - 10 6.8 % -
Adroit Science AB
2.3 %
2 1.9 % 3 2.3 % +35.06%

Sales per region

SEK in Million2021Weight2022Weight Delta
Other
48.2 %
81 61.2 % 70 48.2 % -13.14%
European Union excluding Sweden
43.1 %
14 10.9 % 63 43.1 % +335.26%
Sweden
19.7 %
39 29.5 % 29 19.7 % -26.29%
Internal Eliminations
-11.1 %
-- -16 -11.1 % -

Managers

Managers TitleAgeSince
Justin Pierce CEO
 Chief Executive Officer 51 01/15/01
Petra Sjölin DFI
 Director of Finance/CFO - 01/20/01
Fredrik Andersson COO
 Chief Operating Officer 48 01/99/01
Helena Ossmer Thedius SAM
 Sales & Marketing 48 30/22/30
Simon Jegou PRN
 Corporate Officer/Principal - 01/22/01

Members of the board

Members of the board TitleAgeSince
Mats Gunnar Pettersson BRD
 Director/Board Member 78 01/16/01
Sven-Christer Nilsson BRD
 Director/Board Member 79 01/16/01
Joel Magnus Eklund BRD
 Director/Board Member 44 01/20/01
Hans Henrik Lidgard FOU
 Founder 78 01/94/01
Malin Malmsjö BRD
 Director/Board Member 51 01/16/01
Ingela Fritzon BRD
 Director/Board Member 60 01/19/01
Martin Lidgard BRD
 Director/Board Member 47 01/21/01
Claudia Lindwall BRD
 Director/Board Member 61 01/21/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 10,800,000 2,310,488 ( 21.39 %) 0 21.39 %

Company contact information

Magle Chemoswed Holding AB

Agneslundsvägen 27

212 15, Malmö

+

http://www.maglechemoswed.com
address Magle Chemoswed Holding AB(MAGLE)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Magle Chemoswed Holding AB

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
MAGLE CHEMOSWED HOLDING AB Stock Magle Chemoswed Holding AB
+28.57% 3.23Cr
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+29.41% 68TCr
NOVO NORDISK A/S Stock Novo Nordisk A/S
+30.35% 59TCr
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.78% 36TCr
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.50% 33TCr
ABBVIE INC. Stock AbbVie Inc.
+3.37% 28TCr
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.53% 24TCr
NOVARTIS AG Stock Novartis AG
+10.16% 21TCr
ROCHE HOLDING AG Stock Roche Holding AG
-8.14% 20TCr
AMGEN INC. Stock Amgen Inc.
+7.34% 17TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. MAGLE Stock
  4. Company Magle Chemoswed Holding AB
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW